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Abstract
Background:  The mechanisms and components that regulate macropinocytosis are poorly
understood. Here we have investigated the role of sorting nexin 5 (SNX5) in the regulation of
macropinocytic activity.
Results: SNX5 is abundantly expressed in macrophages, cells very active in macropinocytosis, and
is recruited onto newly-formed macropinosomes. LPS treatment of bone marrow-derived
macrophages resulted in a 2.5 fold decrease in macropinosome formation that correlates with a
reduction in the levels of SNX5. To investigate the relationship between SNX5 levels and
macropinocytic activity we examined the formation of macropinosomes in HEK-FlpIn cells stably
expressing GFP-SNX5. Constitutive macropinocytosis was increased ~2 fold in HEK-GFP-SNX5
cells compared with parental HEK-FlpIn cells. Furthermore, EGF stimulation resulted in a significant
increase in macropinocytosis and there was also a 2.0 fold increase in the generation of
macropinosomes in HEK-GFP-SNX5 cells compared with parental HEK-FlpIn cells. SNX5, which
interacts specifically with PtdIns(3)P and PtdIns(3,4)P2 through its PX domain, was recruited to
regions on the plasma membrane containing EGF receptor or positive for PtdIns(3,4)P2 as detected
with the PH domain of TAPP1. Treatment with AG1478, an EGF receptor specific tyrosine kinase
inhibitor, prevented the recruitment of SNX5 to the cytosolic face of the plasma membrane and
inhibited the formation of macropinosomes in response to EGF treatment.
Conclusion:  Based on these data, we propose that SNX5 requires the generation of
phosphoinositides for recruitment to the plasma membrane and, moreover, influences the level of
macropinocytic activity.
Background
Macropinocytosis is an endocytic process that enables
cells to internalize large amounts of solutes from the
external environment. Macropinosomes are generated
from the base of actin-mediated membrane ruffling when
the lamellipodia folds back onto itself thereby forming
very large endocytic structures. Macropinosomes are het-
erogeneous in size and generally considered to be > 0.2
μm in diameter [1,2], a size considerably larger than clath-
rin-coated vesicles. The formation of macropinosomes is
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largely a signal dependent process that is transiently
induced by growth factors such as macrophage colony-
stimulating factor (M-CSF) and epidermal growth factor
(EGF) or tumour promoting factors such as phorbol myr-
istate acetate (PMA) [3-6]. Given the large size of macropi-
nosomes, this unique organelle provides an efficient route
for non-selective entry of solute macromolecules as well
as considerable amounts of plasma membrane into the
cell [2].
Macropinocytosis is important in a range of physiological
processes. For example, macropinocytosis has a role in the
down-regulation of signalling from the plasma mem-
brane [7] and, because of its dependence upon membrane
ruffling, in cell motility [2]. Consequently macropinocy-
tosis is very relevant to tumour progression and metasta-
sis. In addition, this endocytic pathway is the primary
mechanism by which macrophages and dendritic cells
sample their immediate environment for circulating anti-
gens [8]. Indeed, the major antigen presenting cells,
namely macrophages and dendritic cells, are highly active
in macropinocytosis [8]. For example, macrophages
undergo extensive constitutive macropinocytosis, inter-
nalizing up to 200% of their surface area every hour [9],
patrolling and sampling the environment for their role as
antigen presenting cells of the immune system. Also
immature dendritic cells are able to macropinocytose
large quantities of exogenous solute as part of their senti-
nel function [10]. On the other hand, maturation of den-
dritic cells is associated with down-regulation of
macropinocytosis to maximise the presentation of cap-
tured antigen [11]. In addition to antigen uptake, mac-
ropinocytosis is also considered important in the
chemotactic response of neutrophils and macrophages
[12]. This endocytic pathway is also utilised by various
pathogens such as Salmonella and Shigella to gain entry
into host cells [13].
Despite the physiological relevance of macropinocytosis,
the molecular basis for the regulated formation and mat-
uration of macropinosomes is very poorly understood.
Macropinosome formation in a range of cell types has
been shown to be phosphoinositide-3 kinase dependent
[14] and unlike the relatively well-characterised phago-
some, its regulation is receptor-mediated. As endocytic
compartments mature, the bulk of their protein constitu-
ents are maintained [15]. Peripheral membrane proteins
are differentially recruited in a temporally dependent
manner in response to a shift in the organelle's phosphoi-
nositide composition. The phosphoinositides (PtdIns)
have become the focus of intense interest as they are
linked to a range of cell signalling events and are key reg-
ulators of intracellular membrane trafficking. Whilst
PtdIns(3,4)P2  [16], PtdIns(4,5)P2  [17] and
PtdIns(3,4,5)P3 [18] are traditionally considered to be
associated with signalling at the plasma membrane in
response to extracellular stimuli, the monophosphor-
ylated phosphoinositide PtdIns(3)P, is implicated in the
membrane trafficking of the endosomal system.
Sorting nexins are a large family of proteins characterised
by the presence of a phox (PX) domain at the amino ter-
minus. The modestly conserved PX domain is a sequence
of 70 to 120 residues that has been shown to bind to var-
ious phosphoinositides hence the PX domain confers
phosphoinositide specificity to the protein [19]. Sorting
nexins have roles in endocytic trafficking events [19-21].
One such sorting nexin is SNX5, a 404 residue protein that
contains a central PX domain and large C-terminal
domain predicted to include a BAR domain [22,23], a
domain believed to be involved in membrane curvature
and tubulation. SNX5 was first discovered based on its
homology to SNX1 and subsequently shown to associate
with early endosomes. We have previously reported that
the PX domain of SNX5 binds specifically to PtdIns(3)P
and PtdIns(3,4)P2  [24] and SNX5 is associated with
newly-formed macropinosomes following EGF stimula-
tion [25]. After EGF stimulation of HEK293 cells, large
EEA1- and SNX5-positive structures were detected in close
proximity to membrane ruffles which labelled with fluid
phase markers [25], characteristics that define macropino-
somes. We have also exploited the association of SNX5
with macropinosomes to track their maturation in live
cells [25]. Our previous work showed that the association
of SNX5 with macropinosomes is highly dynamic and
SNX5 is localised not only to the macropinosome body
but also tubules that extend and depart from the newly-
formed macropinosomes [25]. Here, we present data
showing that SNX5 modulates macropinocytic activity as
well as evidence that the generation of phosphoinositides
is involved in the recruitment of SNX5 to the plasma
membrane prior to macropinosome formation.
Methods
Antibodies, conjugates and DNA constructs
Rabbit anti-mouse SNX5 was raised against a synthetic
peptide corresponding to the N-terminal 35 residues of
mouse SNX5, with an additional Cys on the C-terminus,
and affinity purified on a column of peptide conjugated to
SulfoLink Coupling Gel (Pierce, USA). Monoclonal
mouse antibodies to human EEA1 were from BD Trans-
duction Laboratories (California, USA). Mouse mono-
clonal anti-human EGF receptor (EGF-R) antibody (clone
528) has been described [26]. Monoclonal mouse anti-
bodies to α-tubulin, goat anti-rabbit IgG Alexa Fluor® 488,
goat anti-mouse IgG Alexa Fluor® 568, goat anti-mouse
IgG Alexa Fluor® 647, biotinylated EGF complexed to
Alexa Fluor® 555 streptavidin and Texas-Red-X Phalloidin
were purchased from Molecular Probes (Oregon, USA).
Horse-radish peroxidase conjugated rabbit anti-mouseBMC Cell Biology 2008, 9:58 http://www.biomedcentral.com/1471-2121/9/58
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and swine anti-rabbit immunoglobulins were from Dako
(Glastrup, Denmark). Full length human EGF-R was
cloned into the XbaI sites of pCI-neo. The PH domain of
TAPP1 (aa 95–400) was from Dr. S. Dowler (MRC, Uni-
versity of Dundee, Dundee, UK).
Cell culture and transfection
HEK-FlpIn (Invitrogen, USA) and HEK-GFP-SNX5 stable
cells were generated, cultured and transfected as previ-
ously described [24]. Primary bone marrow-derived mac-
rophages (BMMs) were generated by culture of bone
marrow cells for 7 days in M-CSF as described [27]. BMMs
were activated with 10 ng/ml LPS (Sigma-Aldrich, Aus-
tralia) up to 24 h before fixation in 4% paraformaldehyde
(PFA) or preparation for immunoblotting.
Macropinosome analyses
Cell monolayers were cultured for various time periods in
the presence of 100 μg/ml dextran (10,000 MW) conju-
gated to tetramethylrhodamine (TR-dextran) (Molecular
Probes, USA). The cells were then washed with media at
4°C and fixed in 4% PFA. Images were captured using an
LSM 510 Meta confocal microscope and quantified for
macropinosomes using an automated image analysis
pipeline in ImageJ 1.37v (NIH). The 'Substract Back-
ground' functionality was executed, and images thresh-
olded to a binary image. Dextran-positive structures at
least 0.5 μm in diameter were quantified through the
'Analyze Particles' feature.
For analysis of macropinosomes using endosomal mark-
ers, cell monolayers were washed twice using PBS, serum-
starved for 16–24 h at 37°C and stimulated with EGF
(100 ng/ml) (Invitrogen, USA) at 37°C for 10 min. Cells
were then washed twice in PBS, fixed in 4% PFA and
stained using mouse anti-human EEA1 followed by goat
anti-mouse Alexa Fluor 568. Macropinosomes were iden-
tified based on their size (>1 μm) [2], circular structure
and the staining pattern for EEA1 which resembled a halo.
The mean number of macropinosomes from a triplicate of
100 cells was determined. Each experiment was repeated
at least twice without knowledge of the identity of sam-
ples. Counts were performed using the Zeiss Axioplan 2
microscope.
EGF Internalization assay
HEK-GFP-SNX5 cells, transiently transfected with pCI-
neo-EGF-R for 24 h, were serum-starved for 16–24 h at
37°C. Cells were washed twice using ice-cold PBS and
incubated with 100 ng/ml Alexa Fluor 555 conjugated-
EGF (Molecular Probes, USA) in serum-free media for 10
min on ice. Excess EGF was removed by washing the cells
three times in ice-cold PBS. Cells were resuspended in ice-
cold serum-free media (in the absence and presence of
drugs) and the cells were then incubated at 37°C for the
indicated duration to allow EGF internalization. Cells
were then fixed and processed for immunofluorescence
analysis.
Drug treatment
Cell monolayers were washed twice with PBS and serum-
starved for 16–24 h at 37°C. Cells were treated with 100
nM AG1478 (Calbiochem, USA) (from a 10 mM stock in
DMSO) for 15 min at 37°C. EGF (100 ng/ml) (Invitrogen,
USA) was then added to the cells in the presence or
absence of AG1478 at 37°C for the indicated durations.
Cells were then washed twice with PBS and processed for
immunofluorescence.
Indirect immunofluorescence
Cell monolayers grown on poly-L-lysine coated coverslips
were washed twice in PBS and fixed in 4% PFA for 15 min.
Cells were processed for immunofluorescence as previ-
ously described [28] and examined using either a Zeiss
Axioplan 2 microscope or a Leica TCS SP2 laser unit and
Leica Confocal Software version 2.61 or a Zeiss LSM 510
Meta confocal microscope. For multi-colour labelling,
images were collected independently.
Endosome-lysosome fusion assay
Late endosomes and lysosomes of cells were labelled with
fluorescently-conjugated dextran as described previously
[29]. Briefly, cells grown on poly-L-lysine coated cover-
slips were incubated with 100–200 μg/ml dextran conju-
gated to Alexa 647 (MW 10,000 Da) (Molecular Probes,
USA) for 4 h at 37°C. The cells were then thoroughly
washed and further incubated in normal growth media
for 16 h to allow the dextran to accumulate in the late
organelles of the endosomal system. The cells were then
pulsed with 100–200 μg/ml dextran conjugated to TR
(MW 10,000 Da) (Molecular Probes, USA) for 5 min at
37°C to label macropinosomes, washed and chased in
normal media for 4, 10, 15 or 20 min before being fixed
in 4% PFA. The cells were imaged on an LSM 510 Meta
confocal microscope. The proportion of TR-labelled mac-
ropinosomes that had acquired content from the late
endosomes/lysosomes (ie. Alexa 647-positive) were
scored for >50 cells per time point.
Immunoblotting
Proteins were resolved on 10% SDS-polyacrylamide gels
and transferred onto Immobilon-P PVDF membranes
(Millipore, USA) according to the manufacturer's instruc-
tions and immunoblotting performed as described [30].
SNX5 was visualized with rabbit anti-SNX5 followed by
horseradish peroxidase-conjugated anti-rabbit secondary
antibody. Bound antibodies were detected using chemilu-
minescence and images were captured using Gel-Pro™
Analyser version 4.5 software. Bound antibodies were
stripped from the membrane using PVDF membraneBMC Cell Biology 2008, 9:58 http://www.biomedcentral.com/1471-2121/9/58
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stripping buffer (25 mM glycine, 1% (w/v) SDS, PBS, pH
2) as necessary. Membrane was then washed and blocked,
as described above, prior to subsequent incubation with
different primary antibodies.
Statistical Analysis
Data were analysed by an unpaired Student's t-test, two-
tailed.
Results
SNX5 is located on macropinosomes in both cultured and 
primary cells
We have previously shown that GFP-SNX5 is associated
with macropinosomes in HEK-FlpIn cells [25]. The ques-
tion now arises as to whether SNX5 is also a marker of
macropinosomes in primary cells and, if so, what func-
tion SNX5 plays in the process of macropinocytosis. Mac-
rophages are known to have very high rates of
macropinocytosis [31]. Significantly, microarray data has
indicated that macrophages and immature dendritic cells
express very high levels of SNX5 transcripts [32] coincid-
ing with their high macropinocytic activities. Therefore,
we examined if SNX5 is a marker of macropinosomes in
macrophages. Analysis of the intracellular localization of
endogenous SNX5 in bone marrow-derived mouse mac-
rophages (BMMs) differentiated for 7 days in M-CSF
revealed that endogenous SNX5 is associated with endo-
somes and large intracellular structures reminiscent of
macropinosomes (Fig 1A). These large intracellular struc-
tures (0.5–5 μm) were readily labelled after a 3 min pulse
of TR-conjugated dextran confirming them as newly-
formed macropinosomes. Furthermore, BMMs were ana-
lysed by immunoblotting using an affinity purified rabbit
polyclonal antibody to SNX5. A single ~55 kDa compo-
nent, the expected size of SNX5, was detected at abundant
levels in untreated primary macrophages (Fig. 1B). Mac-
ropinocytosis is known to be down-regulated in macro-
phages by the treatment with 10 ng/ml
lipopolysaccharide (LPS) [31]. We examined the number
of macropinosomes formed during a 3 min pulse label-
ling with dextran using an automated image analysis pro-
tocol described in the methods. Untreated BMMs had 723
macropinosomes per 100 cells (n = 213) compared to 305
macropinosome per 100 cells (n = 182) in BMMs treated
with LPS for 24 h (Fig. 1C–D). This 58% reduction in the
number of macropinosomes formed is consistent with
that observed previously using bulk endocytosis markers
[31]. Phalloidin staining of the macrophages indicated
that the cells remained healthy after the 24 h LPS treat-
ment. Immunoblotting showed a 40% reduction in total
level of SNX5 protein in macrophages after a 24 h LPS
treatment (Fig. 1B). This reduced SNX5 level is consistent
with previously published microarray data [33]. Endog-
enous SNX5 is clearly associated with macropinosomes in
these BMMs and collectively, this data shows that SNX5
levels correlates with macropinocytic activity.
SNX5 modulates macropinocytosis
To directly explore the role of SNX5 in macropinocytosis
we have used HEK-FlpIn cells which stably express SNX5-
GFP. This cell line was the previously described HEK-FlpIn
cell line transfected with pcDNA5/FRT-EGFPSNX5,
referred to as HEK-GFP-SNX5 [24]. HEK-GFP-SNX5 is a
polyclonal cell line where the construct is integrated in a
defined chromosomal location and therefore avoids dif-
ferences due to clonal variation. HEK-GFP-SNX5 has over-
all ~2 fold-increase in the level of SNX5 compared with
HEK-FlpIn cells [25], an increase in SNX5 level which was
consistent throughout the course of these studies, as mon-
itored by immunoblotting.
Next we investigated if the elevated level of SNX5 in HEK-
GFP-SNX5 cells modulated the level of macropinocytosis.
To estimate changes in macropinocytosis, newly-formed
macropinosomes were labelled using a 5 min pulse of the
fluid phase marker dextran (10,000 Da). Only dextran-
positive-structures >0.5 μm in diameter were scored as
macropinosomes, and this size-based exclusion will min-
imise any contribution from changes in pinocytosis kinet-
ics. Untreated serum-starved HEK-GFP-SNX5 cells
showed a 1.6 fold increase (p < 0.02) in constitutive mac-
ropinocytosis compared with parental HEK-FlpIn cells
(Fig 2A). Previously we demonstrated that SNX5-positive
macropinosomes were co-labelled with EEA1 and dextran
[25], and EEA1-positive structures (>1 μm in diameter)
were counted as an additional measure of macropino-
some number. This assay also identified a 2.3 fold
increase in the constitutive levels of macropinocytosis in
the HEK-GFP-SNX5 cells (not shown). Together these
data show that elevated levels of SNX5 influences the gen-
eration of macropinosomes.
We then determined the impact of the elevated level of
SNX5 on macropinocytosis after EGF stimulation. After a
5 minute EGF stimulation of serum-starved cells, HEK-
GFP-SNX5 cells exhibited a 2.0 fold increase in the
number of macropinosomes compared to HEK-FlpIn cells
(p < 0.005), utilizing the Dextran-uptake assay (Fig 2A).
These data demonstrate that cells expressing elevated lev-
els of SNX5 have an increase in the capacity for macropi-
nocytosis. Moreover, the increase in both constitutive and
receptor stimulated-macropinocytosis as a consequence
of increased levels of SNX5 indicates that this molecule
plays a role in the generation of these endocytic structures.
Next we investigated the relationship between EGF-R sig-
nalling and macropinocytosis in the stable HEK-GFP-
SNX5 cells using AG1478, an EGF-R specific tyrosine
kinase inhibitor that prevents EGF-R activation [34]. Sig-BMC Cell Biology 2008, 9:58 http://www.biomedcentral.com/1471-2121/9/58
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nificantly, treatment of cells with AG1478 inhibited the
increase in the number of macropinosomes normally
observed when cells are treated with EGF alone (Fig. 2B).
DMSO, the carrier for AG1478, had no impact on the level
of macropinosomes at the same concentration (Fig 2B).
Similar results were obtained in three separate experi-
ments. The data demonstrate that the increased macropi-
nocytic activity of HEK-GFP-SNX5 cells following EGF
binding is in response to cell signalling events.
To determine if the elevated macropinocytic activity
induced by increased levels of SNX5 in HEK-GFP-SNX5
cells can support the internalization of EGF-R, we trans-
fected HEK-GFP-SNX5 cells with EGF-R to increase the
numbers of receptors for detection by immunofluores-
cence. Transfected HEK-GFP-SNX5 cells were incubated
with Alexa555-conjugated EGF on ice, then the cells
washed and incubated at 37°C to allow internalization of
surface bound ligand-receptor complexes. As previously
reported [25], SNX5 and EEA1 are located to distinct
domains of the macropinosome (Fig. 3). After either 5
min (not shown) or 15 min incubation at 37°C, the
majority (84%) of SNX5- and EEA1-labeled macropino-
somes were also labelled with Alexa555-EGF (Fig. 3),
indicating that the activated receptor can be internalized
into these large structures and furthermore suggests that
the formation of these structures from the plasma mem-
branes occurs in the proximity of activated receptors.
SNX5 functions in the formation of macropinosomes
Upon EGF-R activation, SNX5 is recruited to the plasma
membrane and the newly-formed macropinosomes [24]
and is clearly associated during the early maturation
stages of individual macropinosomes [25]. Therefore,
SNX5 may function to drive the formation of new mac-
ropinosomes and/or to regulate the maturation of the
macropinosomes. To determine if elevated levels of SNX5
in the HEK-GFP-SNX5 cells influence the rate of matura-
tion of macropinosomes, we performed experiments to
determine if the delivery of macropinosome contents to
the late endosome/lysosome was altered. The content
mixing assay described by Luzio and colleagues was used
[29] where cells were first exposed to Alexa647-conju-
gated dextran as a fluid phase marker to label late endo-
somes and lysosomes and then the Alexa647-positive cells
incubated in TR-labelled dextran for 5 min, washed and
analyzed over the subsequent 20 min for mixing of the
two fluorochromes as an indication of fusion of the
newly-formed macropinosomes with late endosome/lyso-
some. No difference was detected in the proportion of
macropinosomes that acquired Alexa647-dextran
between parental and HEK-GFP-SNX5 cells (Fig. 4), indi-
cating that the increased levels of SNX5 does not affect
macropinosome maturation rates. This result indicates
that the observed increase in macropinosome number in
HEK-GFP-SNX5 cells is not due to a delay in the kinetics
of maturation. To further compare the maturation kinetics
between the two cells lines we examined the rates of EGF-
R degradation. Immunoblotting of the endogenous EGF-
R was performed to determine the level of receptor at var-
ious time-points after EGF treatment. Importantly the
level of the EGF-R observed prior to the addition of EGF
was the same between both cell lines (not shown). No sig-
nificant difference was observed in the rate at which EGF-
R was degraded in the HEK-GFP-SNX5 cells when com-
pared to the parental cell line (not shown). These two
observations combined indicate that the kinetics of mac-
ropinosome maturation was not altered by the increased
level of SNX5.
Next we investigated if SNX5 recruited to the plasma
membrane after EGF stimulation can influence the rate of
formation of macropinosomes. To determine the spatial
relationship between plasma membrane recruitment and
the location of EGF-R, serum-starved HEK-GFP-SNX5 cells
were treated with EGF for 3 min and non-permeabilised
cells stained with anti-EGF-R antibodies. Although the
staining intensity of the endogenous cell surface EGF-R
was weak, the receptor was detected in the ruffling edges
of the cell and showed a co-localization with GFP-SNX5
(not shown). To enhance the sensitivity, this experiment
was repeated with transfected HEK-GFP-SNX5 cells
expressing elevated levels of EGF-R (Fig. 5A). GFP-SNX5
was not detected on the plasma membrane in serum-
LPS stimulation of primary macrophages results in a decrease in macropinocytic activity and SNX5 levels Figure 1 (see previous page)
LPS stimulation of primary macrophages results in a decrease in macropinocytic activity and SNX5 levels. (A-
D) Bone marrow-derived macrophages were grown for 7 days in M-CSF and then analysed as follows. (A) Cells were cultured 
in the presence of 100 μg/ml TR-conjugated dextran (10,000 MW) for 3 min. The cells were washed at 4°C and fixed in 4% 
PFA and stained with affinity-purified SNX5 antibodies followed by Alexa488-conjugated goat anti-rabbit IgG. Bar = 10 μm. (B) 
Macrophages were seeded at 1 × 107 cells/ml and incubated with 10 ng/ml LPS for up to 24 h, as indicated. Samples (15 μg pro-
tein) were separated by SDS-PAGE and probed by immunoblotting using the anti-SNX5 antibody. (C-D) Macrophages were 
either left untreated or treated with 10 ng/ml LPS for 24 h and then pulsed with 1 mg/ml Alexa 488-conjugated dextran for 3 
minutes at 37°C and fixed in 4% PFA. The samples were then stained with Texas-red-X conjugated phalloidin. Images were 
captured using identical settings for -/+ LPS conditions and counted as described in Methods. At least 180 cells were analysed 
for each condition.BMC Cell Biology 2008, 9:58 http://www.biomedcentral.com/1471-2121/9/58
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starved EGF-R transfected cells prior to EGF treatment,
however, following EGF treatment cell surface GFP-SNX5
was clearly concentrated in the ruffling edges of the cell
and showed a striking co-localization with surface EGF-R
(Fig. 5A).
Activation of EGF-R results in the production of
PtdIns(3,4,5)P3  and its breakdown product,
PtdIns(3,4)P2. We have shown that the PX domain of
SNX5 binds to both PtdIns(3)P as well as PtdIns(3,4)P2.
To determine the relationship of PtdIns(3,4)P2 generated
from activated EGF-R and the plasma membrane recruit-
ment of SNX5, we have used the PtdIns(3,4)P2-specific
probe, mCherry-TAPP1-PH domain [35], to determine
the location of PtdIns(3,4)P2 at the plasma membrane.
HEK-GFP-SNX5 cells were transfected with mCherry-
TAPP1-PH domain, then the cells serum-starved and
treated with EGF for 5 min. mCherry-TAPP1-PH was
located on the plasma membrane of EGF-stimulated cells,
but not non-stimulated cells, and showed co-localization
with GFP-SNX5, demonstrating that SNX5 was recruited
to regions of the plasma membrane rich in PtdIns(3,4)P2
after EGF stimulation (Fig. 5B). Significantly, treatment of
EGF-stimulated cells with AG1478 resulted in the inhibi-
tion of SNX5 recruitment to the plasma membrane (Fig.
5C). Qualitative cell analysis showed a reduction from
~57% to 20% of cells with detectable SNX5 at the cell sur-
face (Fig. 5C). The residual 20% positive cells represents a
level similar to that observed in non-stimulated cells.
Therefore, inhibition of EGF-R tyrosine kinase activity by
AG1478 inhibits the recruitment of SNX5 to the plasma
membrane and the generation of macropinosomes. Taken
together we propose that activation of EGF-R and its effec-
tor kinase PI3K are required for SNX5 recruitment to the
plasma membrane and subsequent generation of mac-
ropinosomes that internalize receptor-EGF complexes.
Discussion
The mechanisms that drive macropinocytosis are poorly
defined. Our previous studies showed that SNX5 associ-
ates with newly-formed macropinosomes following EGF
stimulation [25]. Given the potential of sorting nexins to
have membrane binding and bending properties, medi-
ated by the PX and BAR domains, SNX5 represented a
potential regulator of this endocytic process. SNX5 is
recruited to the plasma membrane following receptor
stimulation and is associated with newly-formed mac-
ropinosomes derived from membrane ruffles. In this
study we have analysed the impact of SNX5 on numerous
aspects of the macropinocytic process. Our results demon-
strate that SNX5 is present in abundant levels in primary
macrophages that possess high intrinsic macropinocytic
activity and that on reduction in macropinocytosis, cell
levels of SNX5 are reduced also. Moreover, stable overex-
pression in HEK293 cells resulted in the recruitment of
Figure 2
SNX5 levels influence macropinocytosis activity. (A) 
HEK-FlpIn parental (white bars) and HEK-GFP-SNX5 (grey 
bars) cells were serum-starved for 16 h and pulsed with 100 
μg/ml dextran (10,000 Da) conjugated to tetramethylrhod-
amine for 5 min in the presence or absence of 100 ng/ml EGF 
at 37°C prior to fixation in 4% PFA. Macropinosomes were 
identified as dextran-positive structures > 0.5 μm in diame-
ter, and counted using an automated image analysis protocol 
as described in Methods. The mean number of macropino-
somes per 100 cells was determined over 500 cell triplicates 
for each condition (B) HEK-GFP-SNX5 cells were serum-
starved overnight and either left untreated or treated with 
100 ng/ml EGF in the presence and absence of 100 nM of 
AG1478, or in the presence of 0.001% DMSO (carrier con-
trol), as indicated. Cells were fixed and permeabilised and 
stained with anti-human EEA1 and Alexa568-conjugated goat 
anti-mouse IgG. Macropinosomes were identified as large >1 
μm EEA1 positive-structures, as described in text. The mean 
number of macropinosomes from a triplicate of 100 cells was 
determined without knowledge of the identity of sample. 
Each experiment was repeated twice. Shown is mean and 
error bars represent standard deviation. ** p < 0.05, *** p < 
0.005.BMC Cell Biology 2008, 9:58 http://www.biomedcentral.com/1471-2121/9/58
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SNX5 to the cell surface following EGF stimulation and in
a significant increase in the number of newly-formed mac-
ropinosomes. Upon abrogation of the cell-surface recruit-
ment of SNX5 via inhibition of EGF-R tyrosine kinase
activity, the generation of macropinosomes is substan-
tially reduced. Collectively the data indicates SNX5 is a
molecular component of macropinocytosis specifically
involved in the biogenesis and formation of macropino-
somes.
The PX domain of SNX5 has the capacity to bind both
PtdIns(3)P and PtdIns(3,4)P2. [24]. The PI binding specif-
icity of SNX5 contrasts with SNX1 which binds selectively
PtdIns(3)P  and PtdIns(3,5)P2, also based on liposome
binding assays [36]. The plasma membrane recruitment
of SNX5 following EGF stimulation is likely to be depend-
ent on an interaction with PtdIns(3,4)P2. Cell signalling is
essential for the recruitment of SNX5 to the cytosolic face
of the plasma membrane, as AG1478 inhibited the move-
ment of SNX5 to the plasma membrane, presumably due
to the lack of PtdIns(3,4,5)P3 and its breakdown product
PtdIns(3,4)P2.. However, AG1478 does not prevent EGF-
R internalization via the clathrin-dependent pathway
(unpublished observations), indicating, at least in this
system that receptor dimerization is sufficient for clathrin-
mediated endocytosis, and consistent with previous find-
ings [37].
EGF-R is internalized into macropinosomes in HEK-GFP-SNX5 cells Figure 3
EGF-R is internalized into macropinosomes in HEK-GFP-SNX5 cells. (A) HEK-GFP-SNX5 cells were transfected 
with EGF-R and 24 h later incubated with Alexa555-conjugated EGF on ice. After washing, cells were incubated at 37°C for 15 
min, then fixed and permeabilised and stained with human anti-EEA1 antibody followed by Alexa647-conjugated anti-human 
IgG. Insert shows overlay of GFP, SNX5 and EEA1. In inset, bar = 5 μm.
Elevated SNX5 does not impact on macropinosome matura- tion Figure 4
Elevated SNX5 does not impact on macropinosome 
maturation. HEK-FlpIn parental (white bars) or HEK-GFP-
SNX5 (black bars) cell monolayers were cultured in the 
presence of 100 μg/ml Alexa647-conjugated dextran (10,000 
MW) for 4 h at 37°C, washed and incubated overnight to 
label the late endosomes and lysosomes. The cells were then 
incubated with 100 μg/ml TR-labeled dextran (10,000 MW) 
for 5 min at 37°C, washed and then incubated at 37°C in 
serum free media for up to 20 min, as indicated, to internal-
ize the TR-labeled dextran. Monolayers were fixed in 4% PFA 
and the samples mounted and images captured using a confo-
cal microscope. The proportion of macropinosomes that had 
fused and acquired content from the late endosomes/lyso-
somes was scored.BMC Cell Biology 2008, 9:58 http://www.biomedcentral.com/1471-2121/9/58
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Figure 5 (see legend on next page)BMC Cell Biology 2008, 9:58 http://www.biomedcentral.com/1471-2121/9/58
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Given the association of EGF signalling and the behaviour
of SNX5, it is formally possible that SNX5 is modulating
the EGF-R signalling cascade and thereby influencing
macropinocytosis indirectly. However, our data argues for
a direct role of SNX5 in enhancing the early events of mac-
ropinocytosis rather than potentiating EGF-R signalling.
Firstly, constitutive macropinocytosis in the absence of
EGF stimulation is increased >2 fold in HEK-GFP-SNX5
cells compared with parental HEK-FlpIn cells. Secondly,
the kinetics of macropinosome maturation and the rate of
EGF-R degradation is similar in parental and HEK-GFP-
SNX5 cells following EGF stimulation, indicating SNX5 is
promoting the early events driving the biogenesis of mac-
ropinosomes, but does not influence the rate of matura-
tion and delivery to lysosomes.
A number of the SNXs can form homodimers and het-
erodimers in vitro and in vivo. As SNX5 has a coiled-coil C-
terminal and a predicted BAR domain, it is likely that it
exists as a dimer. We have previously demonstrated that
SNX5 does not form a homodimer but can associate with
SNX1 and that association of SNX5 with endosomes
appears to be dependent on the formation of SNX5/SNX1
heterodimers [25]. SNX5 is selectively recruited to mem-
brane ruffles of activated cells and is not associated with
SNX1 [24]. Therefore it is likely that SNX5 exists in two
pools, one pool independent of SNX1 and another pool
as a heterodimer with SNX1. We propose that a SNX1-
independent pool of SNX5 is recruited to the plasma
membrane to initiate the formation of macropinosomes
whereas the SNX5/SNX1 pool is recruited to a subdomain
of maturing macropinosomes to promote tubulation. Fur-
thermore, the differential recruitment of SNX5 to either
plasma membrane or nascent macropinosomes is likely to
be dependent on the specificity of phosphoinositide bind-
ing. Clearly further studies are required to identify the
partners of SNX5.
Conclusion
Based on our published data [24,25] and the data above,
our model for macropinosome maturation is as follows.
Following receptor stimulation, GFP-SNX5 is recruited to
discrete patches on the cytoplasmic surface of the plasma
membrane via its phosphoinositide binding PX domain.
There is a direct relationship between the level of cell sur-
face SNX5 protein and macropinocytic activity, highlight-
ing the role for this sorting nexin in driving this signal-
activated endocytosis pathway. Newly-formed SNX5-pos-
itive macropinosomes recruit EEA1 and the retromer com-
plex, possibly mediated by PtdIns(3)P arising from the
hydrolysis of PtdIns(3,4)P2. The BAR domain of SNX5, in
a complex with other sorting nexins, has the potential to
distort the limiting membrane of the macropinosome
into extensive tubular elements that subsequently sepa-
rate from the macropinosome and traffic in a microtu-
bule-dependent manner to perinuclear endosomes. As the
tubular structures depart from the macropinosome there
is a reduction in the surface area of the macropinosome,
which matures into a Rab7-positive structure and eventu-
ally fuses with late endosomes/lysosomes. The identifica-
tion of machinery that regulates this process now provides
the ability to directly assess the biological role of macropi-
nocytosis in a range of physiological settings.
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